Component
Gut contents from myricetin-treated diabetic mice
Context-specific entity; species, compartment and exposure are stated on each claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Transferring gut contents from myricetin-treated donors improved recipient cardiac/barrier measurements and reduced TLR4/MyD88-pathway protein readouts.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Diabetic mouse donor/recipient transplantation; parent myricetin checked by HPLC in transplant material.
- limitations
- Does not isolate one bacterium or metabolite as sufficient; absence of detected parent does not exclude all carried metabolites.
- nutrient_topic
- Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
- plain_language
- A transferable gut-associated effect was tested.
- primary_references
- Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38472186/ · DOI 10.1038/s41387-024-00268-4
Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 556–562
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Diabetic mouse donor/recipient transplantation; parent myricetin checked by HPLC in transplant material. · source_derived_draft · unverified_draft
## myricetin-mouse-fmt A transferable gut-associated effect was tested. Transferring gut contents from myricetin-treated donors improved recipient cardiac/barrier measurements and reduced TLR4/MyD88-pathway protein readouts. Model: Diabetic mouse donor/recipient transplantation; parent myricetin checked by HPLC in transplant material. Limitations: Does not isolate one bacterium or metabolite as sufficient; absence of detected parent does not exclude all carried metabolites. Evidence access: Primary full text Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38472186/ · DOI 10.1038/s41387-024-00268-4
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.